Metabolic studies with trans-5-amino-3-(2-(5-nitro-2-furyl)vinyl)-1,2,4-(5- 14 C)oxadiazole (SQ 18,506). 1. Reductive cleavage of the 1,2,4-oxadiazole ring.
D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D002855:Chromatography, Thin Layer; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008892:Milk / Q000201:enzymology; D009249:NADP / Q000378:metabolism; D009574:Nitro Compounds; D010069:Oxadiazoles / Q000008:administration & dosage / Q000378:metabolism* / Q000652:urine; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism; D010627:Phenethylamines / Q000378:metabolism; D014510:Urease / Q000378:metabolism; D014969:Xanthine Oxidase / Q000378:metabolism
D002247:Carbon Isotopes; D009574:Nitro Compounds; D010069:Oxadiazoles; D010627:Phenethylamines; D002245:Carbon Dioxide; D009249:NADP; D010088:Oxidoreductases; D014969:Xanthine Oxidase; D014510:Urease